Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Foghorn Therapeutics (FHTX) Debt Ratio (2020)

Foghorn Therapeutics has reported Debt Ratio over the past 1 years, most recently at 0.08 for Q4 2020.

  • Quarterly results put Debt Ratio at 0.08 for Q4 2020, changed N/A from a year ago — trailing twelve months through Dec 2020 was 0.08 (changed N/A YoY), and the annual figure for FY2020 was 0.08, changed.
  • Debt Ratio for Q4 2020 was 0.08 at Foghorn Therapeutics, down from 0.1 in the prior quarter.
  • Over the last five years, Debt Ratio for FHTX hit a ceiling of 0.1 in Q3 2020 and a floor of 0.08 in Q4 2020.